747 related articles for article (PubMed ID: 12173132)
41. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of Trichomonas vaginalis infection in and around Surat.
Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis of Trichomonas vaginalis in female children and adolescents evaluated for possible sexual abuse: a comparison of the InPouch TV culture method and wet mount microscopy.
Gallion HR; Dupree LJ; Scott TA; Arnold DH
J Pediatr Adolesc Gynecol; 2009 Oct; 22(5):300-5. PubMed ID: 19576816
[TBL] [Abstract][Full Text] [Related]
44. A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid.
Akyol D; Mungan T; Baltaci V
Arch Gynecol Obstet; 2000 Jul; 264(1):20-3. PubMed ID: 10985613
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea.
Kim SR; Kim JH; Gu NY; Kim YS; Hong YC; Ryu JS
Korean J Parasitol; 2016 Apr; 54(2):187-90. PubMed ID: 27180577
[TBL] [Abstract][Full Text] [Related]
46. Trichomonas vaginalis infection: risk indicators among women attending for routine gynecologic examination.
Verteramo R; Calzolari E; Degener AM; Masciangelo R; Patella A
J Obstet Gynaecol Res; 2008 Apr; 34(2):233-7. PubMed ID: 18412787
[TBL] [Abstract][Full Text] [Related]
47. Trichomonas vaginalis detection using real-time TaqMan PCR.
Schirm J; Bos PA; Roozeboom-Roelfsema IK; Luijt DS; Möller LV
J Microbiol Methods; 2007 Feb; 68(2):243-7. PubMed ID: 17005275
[TBL] [Abstract][Full Text] [Related]
48. A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis.
Antonelli NM; Diehl SJ; Wright JW
Am J Obstet Gynecol; 2000 May; 182(5):1008-10. PubMed ID: 10819810
[TBL] [Abstract][Full Text] [Related]
49. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis.
Kengne P; Veas F; Vidal N; Rey JL; Cuny G
Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):819-31. PubMed ID: 7812190
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria.
Anorlu RI; Fagbenro Beyioku AF; Fagorala T; Abudu OO; Galadanci HS
Niger Postgrad Med J; 2001 Dec; 8(4):183-6. PubMed ID: 11922025
[TBL] [Abstract][Full Text] [Related]
51. [Prevention of vaginal trichomoniasis].
Prill HJ
Ther Ggw; 1972 Aug; 111(8):1120-9. PubMed ID: 4537947
[No Abstract] [Full Text] [Related]
52. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
53. Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas.
Smith KS; Tabrizi SN; Fethers KA; Knox JB; Pearce C; Garland SM
Int J STD AIDS; 2005 Dec; 16(12):811-5. PubMed ID: 16336764
[TBL] [Abstract][Full Text] [Related]
54. Dealing with trichomoniasis.
Young F
J Fam Health Care; 2006; 16(5):153-5. PubMed ID: 17139977
[TBL] [Abstract][Full Text] [Related]
55. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
[TBL] [Abstract][Full Text] [Related]
57. Temporal associations with declining Trichomonas vaginalis diagnosis rates among women in the state of Victoria, Australia, 1947 to 2005.
Marrone J; Fairley CK; Saville M; Bradshaw C; Bowden FJ; Horvath LB; Donovan B; Chen M; Hocking JS
Sex Transm Dis; 2008 Jun; 35(6):572-6. PubMed ID: 18354342
[TBL] [Abstract][Full Text] [Related]
58. Trichomonas vaginalis and bacterial vaginosis. Coexistence in vaginal wet mount preparations from pregnant women.
Franklin TL; Monif GR
J Reprod Med; 2000 Feb; 45(2):131-4. PubMed ID: 10710744
[TBL] [Abstract][Full Text] [Related]
59. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.
Brown HL; Fuller DD; Jasper LT; Davis TE; Wright JD
Infect Dis Obstet Gynecol; 2004; 12(1):17-21. PubMed ID: 15460191
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples.
Madico G; Quinn TC; Rompalo A; McKee KT; Gaydos CA
J Clin Microbiol; 1998 Nov; 36(11):3205-10. PubMed ID: 9774566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
